Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oseltamivir treatment versus treatment plus prophylaxis for influenza outbreaks in residential aged care facilities
ACTRN12615000638538Phase 3Not yet recruiting
- Sponsor
- Children's Hospital, Westmead: National Centre for Immunisation Research and Surveillance
- Start
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of oseltamivir in influenza (2 arms), sponsored by Children's Hospital, Westmead: National Centre for Immunisation Research and Surveillance. Primary endpoint: Attack rate of influenza. Planned start Jun 2016; status: not yet recruiting.
02
Drugs
oseltamivir
03
Conditions
influenza
Beyond the preview
Go deeper on ACTRN12615000638538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615000638538.